In recent years, strategies have been developed to reduce OHSS risk, and the adoption of GnRH agonist triggering in combination with a policy of freeze-all embryos can eliminate the severe type of OHSS [73]. This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.